Infection Control Market - Trends Forecast Till 2028

Infection Control Market, By Type (Equipment, Services, Consumables and Accessories, Protective Barriers, Endoscope Reprocessing Products, Others), End User (Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Life Science Industry, Food Industry, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-ICM-36

Format:  

Number of Pages: 246

Domain: Healthcare

Infection Control Market – Trends Forecast Till 2028

The global infection control market is anticipated to reach USD 26.4 billion by 2020 growing at a CAGR of 6.2% during the forecasting period, 2020-2028. Infection control helps in preventing and stopping the spread of infections in healthcare settings. It is grounded in infectious diseases, epidemiology, social science, and health system strengthening. Factors such as the rising number of surgical procedures and technological advancements in sterilization equipment are some of the major drivers for the infection control market

Infection Control Market – Trends Forecast Till 2028

The global infection control market is segmented into type, end-user, and geography.

The type segment is segmented into Equipment, Services, Consumables and Accessories, Protective Barriers, Endoscope Reprocessing Products, and Others. The equipment segment is further segmented into Disinfectors segment, Washers, Flushers, Endoscope Reprocessor, and Sterilization Equipment. The sterilization equipment segment is further segmented into Heat Sterilization Equipment, Low-Temperature Equipment, Radiation Equipment, Filtration Equipment, Liquid Temperature Equipment, Others. The low-Temperature Equipment segment is further segmented into Hydrogen Peroxide Sterilization, Ethylene Oxide Sterilization (ETO), Formaldehyde Sterilization, and Others. The services segment is segmented into Contract Sterilization, Waste Disposal, and Other Hormonal Therapies. Contract Sterilization segment is further segmented into Ethylene Oxide Sterilization, E-Beam Sterilization, Gamma Sterilization, Steam Sterilization Services, and Others. Other Hormonal Therapies is further segmented into Zoladex (Goserelin Acetate), Faslodex (Fulvestrant), Halotestin (Fluoxymesterone). Consumables and Accessories segment is segmented into waste disposal, disinfectants and cleaning products, cleaning products, lubricants and cleaning solution, disinfection and cleaning accessories, sterilization indicators, personal protective equipment, packaging accessories, others. Protective Barriers segment is segmented into medical nonwovens, covers and closures, goggles. Endoscope Reprocessing Products is segmented into consumables and equipment.

The end-User segment is segmented into Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Life Science Industry, Food Industry, Others

Geographically, the global infection control market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

North America region is the largest contributor to the infection control market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Key players in the global infection control market are Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services LLC, Celgene Corporation, Astellas Pharma Inc.,  Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Abbvei Inc., Genentech, Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed  among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2018, Bristol-Myers Squibb Company has announced the collaboration with the Vedanta Biosciences for evaluating Bristol-Myers Squibb's programmed death-1 (PD-1) immune checkpoint inhibitor
  • In 2018, Kite, a Gilead Company has announced a collaboration with the Sangamo Therapeutics for modifying the genes through Sangamo Therapeutics’ zinc finger nuclease (ZFN) gene-editing technology platform to develop autologous and allogeneic next-generation ex vivo cell therapies for different cancers

Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.

Available Customizations

In addition to the market data for the infection control market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the infection control market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global infection control market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the infection control market.

The primary Respondent breakdown is provided below:

Infection Control Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the infection control market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the infection control market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 26.4 billion

Growth Rate

CAGR of 6.2% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Type, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services LLC, Celgene Corporation, Astellas Pharma Inc.,  Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Abbvei Inc., Genentech, Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed  

Available Customization 

In addition to the market data for the infection control market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

 

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.